Cargando...
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series
BACKGROUND: Chorea in Huntington's Disease (HD) is usually treated with antidopaminergic neuroleptics like haloperidol, olanzapine and tiaprid or dopamine depleting drugs like tetrabenazine. Some patients with hyperkinesia, however, react to treatment with antidopaminergic drugs by developing e...
Gardado en:
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
BioMed Central
2006
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1413552/ https://ncbi.nlm.nih.gov/pubmed/16507108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-6-11 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|